Activity of Plasmid Replicons in CAULOBACTER CRESCENTUS : Rp4 and Cole1

Por O'Neill, Edward A., Berlinberg, Craig, Bender, Robert A.
Publicado em 1983

Characteristics of Elderly Patients Initiating Sitagliptin or Non-DPP-4-Inhibitor Oral Antihyperglycemic Agents: Analysis of a Cross-Sectional US Claims Database

Por Wang, Tongtong, McNeill, Ann Marie, Chen, Yong, O’Neill, Edward A., Engel, Samuel S.
Publicado no Diabetes Ther (2018)

Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials

Por Raji, Annaswamy, Long, Jianmin, Lam, Raymond L. H., O’Neill, Edward A., Engel, Samuel S.
Publicado no Diabetes Ther (2018)

Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

Por Ommen, Elizabeth S., Xu, Lei, O’Neill, Edward A., Goldstein, Barry J., Kaufman, Keith D., Engel, Samuel S.
Publicado no Diabetes Ther (2015)

Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials

Por Ommen, Elizabeth S., Xu, Lei, O’Neill, Edward A., Goldstein, Barry J., Kaufman, Keith D., Engel, Samuel S.
Publicado no Diabetes Ther (2015)

A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadeq...

Por Gantz, Ira, Okamoto, Taro, Ito, Yuka, Sato, Asako, Okuyama, Kotoba, O’Neill, Edward A., Engel, Samuel S., Lai, Eseng
Publicado no Diabetes Ther (2017)

Efficacy and Safety of Sitagliptin Compared with Dapagliflozin in People ≥ 65 Years Old with Type 2 Diabetes and Mild Renal Insufficiency

Por Raji, Annaswamy, Xu, Zhi Jin, Lam, Raymond L. H., O’Neill, Edward A., Kaufman, Keith D., Engel, Samuel S.
Publicado no Diabetes Ther (2020)

A randomized, placebo‐ and sitagliptin‐controlled trial of the safety and efficacy of omarigliptin, a once‐weekly dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2...

Por Gantz, Ira, Okamoto, Taro, Ito, Yuka, Okuyama, Kotoba, O'Neill, Edward A., Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
Publicado no Diabetes Obes Metab (2017)

A randomised, double‐blind, trial of the safety and efficacy of omarigliptin (a once‐weekly DPP‐4 inhibitor) in subjects with type 2 diabetes and renal impairment

Por Chacra, Antonio, Gantz, Ira, Mendizabal, Geraldine, Durlach, Lucila, O'Neill, Edward A., Zimmer, Zachary, Suryawanshi, Shailaja, Engel, Samuel S., Lai, Eseng
Publicado no Int J Clin Pract (2017)

A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus

Por Gantz, Ira, Chen, Menghui, Suryawanshi, Shailaja, Ntabadde, Catherine, Shah, Sukrut, O’Neill, Edward A., Engel, Samuel S., Kaufman, Keith D., Lai, Eseng
Publicado no Cardiovasc Diabetol (2017)

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoS...

Por Scott, Russell, Morgan, Jerry, Zimmer, Zachary, Lam, Raymond L. H., O'Neill, Edward A., Kaufman, Keith D., Engel, Samuel S., Raji, Annaswamy
Publicado no Diabetes Obes Metab (2018)

Randomized clinical trial comparing the efficacy and safety of treatment with the once‐weekly dipeptidyl peptidase‐4 (DPP‐4) inhibitor omarigliptin or the once‐daily DPP‐4 inhibito...

Por Goldenberg, Ronald, Gantz, Ira, Andryuk, Paula J., O'Neill, Edward A., Kaufman, Keith D., Lai, Eseng, Wang, Yin Na, Suryawanshi, Shailaja, Engel, Samuel S.
Publicado no Diabetes Obes Metab (2017)

A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequ...

Por Lee, Seung-Hwan, Gantz, Ira, Round, Elizabeth, Latham, Melanie, O’Neill, Edward A., Ceesay, Paulette, Suryawanshi, Shailaja, Kaufman, Keith D., Engel, Samuel S., Lai, Eseng
Publicado no BMC Endocr Disord (2017)

Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co‐administered to Chinese patients with type 2 diabetes mellitus

Por Ji, Linong, Han, Ping, Wang, Xiaoyue, Liu, Jingdong, Zheng, Shaoxiong, Jou, Ying‐Ming, O'Neill, Edward A, Golm, Gregory T, Engel, Samuel S, Kaufman, Keith D, Shankar, R Ravi
Publicado no J Diabetes Investig (2016)

Double‐blind, randomized clinical trial assessing the efficacy and safety of early initiation of sitagliptin during metformin uptitration in the treatment of patients with type 2 d...

Por Frias, Juan P., Zimmer, Zachary, Lam, Raymond L.H., Amorin, Guillermo, Ntabadde, Catherine, Iredale, Carol, O'Neill, Edward A., Engel, Samuel S., Kaufman, Keith D., Makimura, Hideo, Crutchlow, Michael F.
Publicado no Diabetes Obes Metab (2019)

Double‐blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin gl...

Por Roussel, Ronan, Duran‐García, Santiago, Zhang, Yilong, Shah, Suneri, Darmiento, Carolyn, Shankar, R. Ravi, Golm, Gregory T., Lam, Raymond L. H., O'Neill, Edward A., Gantz, Ira, Kaufman, Keith D., Engel, Samuel S.
Publicado no Diabetes Obes Metab (2018)

Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control

Por Bays, Harold E, Brinton, Eliot A, Triscari, Joseph, Chen, Erluo, Maccubbin, Darbie, MacLean, Alexandra A, Gibson, Kendra L, Ruck, Rae Ann, Johnson-Levonas, Amy O, O’Neill, Edward A, Mitchel, Yale B
Publicado no Vasc Health Risk Manag (2015)

Biochemical characterization of cholesteryl ester transfer protein inhibitors

Por Ranalletta, Mollie, Bierilo, Kathleen K., Chen, Ying, Milot, Denise, Chen, Qing, Tung, Elaine, Houde, Caroline, Elowe, Nadine H., Garcia-Calvo, Margarita, Porter, Gene, Eveland, Suzanne, Frantz-Wattley, Betsy, Kavana, Mike, Addona, George, Sinclair, Peter, Sparrow, Carl, O'Neill, Edward A., Koblan, Ken S., Sitlani, Ayesha, Hubbard, Brian, Fisher, Timothy S.
Publicado em 2010